Advertisement
Clinical Review
CLINICIAN'S CORNER
JAMA. 2004;292(9):1074-1080. doi: 10.1001/jama.292.9.1074

Systolic Hypertension in Older Persons

  1. Sarwat I. Chaudhry, MD;
  2. Harlan M. Krumholz, MD, SM;
  3. JoAnne Micale Foody, MD
  1. Author Affiliations: Department of Veterans Affairs, West Haven Veterans Affairs Medical Center, West Haven, Conn (Dr Chaudhry); Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine (Drs Krumholz and Foody), Center for Outcomes Research and Evaluation, Yale New Haven Hospital (Dr Krumholz), Department of Epidemiology and Public Health, Section of Health Policy and Administration (Dr Krumholz), and The Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine (Dr Krumholz), New Haven, Conn.

Abstract

Context  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure emphasizes the importance of systolic hypertension (SH), defined as systolic blood pressure (SBP) of at least 140 mm Hg and diastolic blood pressure of less than 90 mm Hg, in older persons (≥60 years).

Objective  To systematically review the literature on clinical management of SH in older persons.

Data Sources  We performed a MEDLINE search of English-language literature from 1966-2004 to identify reports about SH in older persons, with particular emphasis on data from randomized clinical trials.

Study Selection and Data Extraction  We selected 1064 studies by using the search terms hypertension combined with the terms systole (or systolic) and aged.

Data Synthesis  There is strong evidence from clinical trials to support the treatment of SH in older persons with SBP of at least 160 mm Hg. Large-scale trials to assess the value of antihypertensive therapy for older patients with SBP of 140 to 159 mm Hg have not been performed, and recommendations to treat these patients are based on observational studies that show a graded relationship of cardiovascular risk with increasing SBP. The studies most strongly support the use of thiazide diuretics and long-acting calcium channel blockers as first-line therapy to treat SH.

Conclusions  Treatment of SH in older patients with SBP of at least 160 mm Hg is supported by strong evidence. The evidence available to support treatment of patients to the level of 140 mm Hg or those with baseline SBP of 140 to 159 mm Hg is less strong; thus, these treatment decisions should be more sensitive to patient preferences and tolerance of therapy.

« Previous | Next Article »Table of Contents

More in JAMA & Archives Journals